+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07197164

Evaluating a 10-Day Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients Who Are Asymptomatic or Have Mild Symptoms

Led by Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia · Updated on 2025-09-29

15

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a treatment approach for kidney transplant patients who test positive for COVID-19 but have no or mild symptoms. The study aims to assess whether starting antiviral therapy with remdesivir shortly before transplant and continuing for 10 days can prevent severe COVID-19 complications. This Phase 2 trial responds to evolving transplant practices during the pandemic and limited data on transplant safety in SARS-CoV-2 positive recipients. Participants will receive remdesivir, starting with a 200 mg dose within 24 -12 hours before their transplant surgery, followed by 100 mg daily for 9 more days, totaling 10 days of treatment. The study includes patients with end-stage kidney disease scheduled for transplant who recently tested positive for SARS-CoV-2 and meet vaccination and symptom criteria. This single-arm trial focuses solely on remdesivir treatment without a comparison group. During the study, researchers will monitor participants for severe COVID-19 development up to 90 days after transplant. They will also track deaths, symptom resolution, hospital stay duration, viral clearance, treatment side effects, and graft complications at various time points. The total study participation includes follow-up visits and assessments extending to six months post-transplant to evaluate safety and treatment impact comprehensively.

CONDITIONS

Brief Title

Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients

Research Team

A

Alba Romero Caballero, MD, MSc

C

Cristina Herrero Sánchez

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here